12 Health Care Stocks Moving In Tuesday's After-Market Session

ENDRA Life Sciences Inc.
Apimeds Pharmaceuticals US, Inc.
China Pharma Holdings, Inc.
Adagio Medical Holdings, Inc
Lexaria Bioscience Corp.

ENDRA Life Sciences Inc.

NDRA

0.00

Apimeds Pharmaceuticals US, Inc.

APUS

0.00

China Pharma Holdings, Inc.

CPHI

0.00

Adagio Medical Holdings, Inc

ADGM

0.00

Lexaria Bioscience Corp.

LEXX

0.00

Gainers

  • ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-market session. The market value of their outstanding shares is at $6.2 million.
  • Apimeds Pharmaceuticals (AMEX:APUS) shares rose 10.06% to $0.7. The company's market cap stands at $9.7 million.
  • China Pharma Holding (AMEX:CPHI) stock increased by 9.62% to $8.88. The company's market cap stands at $36.8 million.
  • Adagio Medical Holdings (NASDAQ:ADGM) stock increased by 9.23% to $0.48. The market value of their outstanding shares is at $11.3 million.
  • Lexaria Bioscience (NASDAQ:LEXX) shares increased by 8.34% to $0.6. The market value of their outstanding shares is at $14.8 million.
  • Nexalin Technology (NASDAQ:NXL) shares moved upwards by 5.92% to $0.51. The market value of their outstanding shares is at $10.8 million.

Losers

  • Catheter Precision (AMEX:VTAK) shares fell 21.0% to $0.39 during Tuesday's after-market session. The market value of their outstanding shares is at $1.8 million.
  • Zhengye Biotechnology (NASDAQ:ZYBT) stock declined by 11.93% to $2.51. The company's market cap stands at $379.6 million.
  • Dyne Therapeutics (NASDAQ:DYN) stock declined by 11.83% to $21.0. The company's market cap stands at $3.8 billion.
  • Pomdoctor (NASDAQ:POM) stock declined by 11.21% to $0.8. The company's market cap stands at $102.5 million.
  • Niki BioSolutions (NASDAQ:NIKI) stock fell 9.31% to $8.67. The company's market cap stands at $71.9 million.
  • First Tracks (NASDAQ:TRAX) stock decreased by 8.51% to $34.19. The company's market cap stands at $1.2 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.